Antiviral Chemotherapy 5 / Advances in Experimental Medicine and Biology Bd.458 (PDF)
New Directions for Clinical Application and Research
(Sprache: Englisch)
Scientists and clinicians attending the last "New Directions in Antiviral Therapy" conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of...
sofort als Download lieferbar
eBook (pdf)
Fr. 177.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Antiviral Chemotherapy 5 / Advances in Experimental Medicine and Biology Bd.458 (PDF)“
Scientists and clinicians attending the last "New Directions in Antiviral Therapy" conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Bibliographische Angaben
- 2012, 1999, 271 Seiten, Englisch
- Herausgegeben: John Mills, Paul A. Volberding, Lawrence Corey
- Verlag: Springer, New York
- ISBN-10: 1461547431
- ISBN-13: 9781461547433
- Erscheinungsdatum: 06.12.2012
Abhängig von Bildschirmgrösse und eingestellter Schriftgrösse kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Grösse: 33 MB
- Mit Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Antiviral Chemotherapy 5 / Advances in Experimental Medicine and Biology Bd.458"
0 Gebrauchte Artikel zu „Antiviral Chemotherapy 5 / Advances in Experimental Medicine and Biology Bd.458“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Antiviral Chemotherapy 5 / Advances in Experimental Medicine and Biology Bd.458".
Kommentar verfassen